Trademarkia Logo

Australia

AU$
XERNA
Protected: Registered/protected

Last updated on 4 May 2022

Owner Info

OncXerna Therapeutics, Inc.

300 Fifth Avenue, Suite 6040

Waltham MA 02451, UNITED STATES OF AMERICA

Serial Number

2249951 filed on 16 Jul 2021

Correspondent

Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.

1100 New York Avenue, N.W.,

Washington DC 20005,

UNITED STATES OF AMERICA

XERNA

Classification Information


Class [001]
Chemical preparations for use in analyzing DNA or RNA for scientific purposes; kits comprising chemical preparations for use in analyzing DNA or RNA f Read More

Class [005]
Chemical preparations for laboratory and diagnostic use in the medical, veterinary or pharmaceutical field, namely, chemical preparations for use in r Read More

Class [009]
Downloadable computer software for use in analyzing, managing, visualizing and storing data; computer software for measuring, testing, analyzing, and Read More

Class [010]
Medical test kits, comprising specimen collection tubes and containers for collecting patient specimens, used in connection with the detection of gene Read More

Class [042]
Medical tests, namely, providing reference and clinical laboratory tests for medical research which detect gene mutations associated with cancer, and Read More

Mark Details


Serial Number

2249951

Registered On

16 Jul 2021

Renewal On

16 Jul 2031

Mark Type

WORD

Priority Claim (Convention Details)


Date

9 Apr 2021

Mark Type

US

Legal History


Show more

Status DateAction Taken
4th May 2022International Registration in Australia Protected correspondence sent
3rd May 2022IP Right Registration Published
3rd May 2022Status change to Registered/Protected
24th Feb 2022Application Accepted correspondence sent
23rd Feb 2022IP Right has been Examined
23rd Feb 2022IP Right Acceptance Published
23rd Feb 2022Status change to Accepted
23rd Feb 2022Awaiting examination
23rd Feb 2022Examination expedited
17th Feb 2022IP Right Filed Published